Drug Therapy
Drugs are approved in the U.S. by the Food and Drug Administration (FDA) for specific purposes to help guide medical practice.
Related Resources
Hereditary Hemorrhagic Telangiectasia: From Molecular Biology to Patient Care
Scientific Literature – 2010Journal of Thrombosis and Haemostasis. Authors: S. Dupuis-Girod, S. Bailly, and H. Plauchu. This article is available for public use and does not require purchase. Click to view the full article.
MoreAntiestrogen Therapy for HHT: A Double-Blind Placebo-Controlled Clinical Trial
Scientific Literature – 2009Laryngoscope. Authors: Eitan Yaniv, Michal Preis, Tuvia Hadar, Jacob Shvero, and Miriam Haddad. This article can be purchased directly from the publisher. Click to view the article description and purchase options.
MorePharmacokinetic-Pharmacodynamic Correlation from Mouse to Human with Pazopanib, a Multikinase Angiogenesis Inhibitor with Potent Antitumor and Antiangiogenic Activity
Scientific Literature – 2007Molecular Cancer Therapeutics. Authors: Rakesh Kumar, Victoria B. Knick, Sharon K. Rudolph, Jennifer H. Johnson, Renae M. Crosby, Ming-Chih Crouthamel, Teresa M. Hopper, Charles G. Miller, Laura E. Harrington, James A. Onori, Robert J. Mullin, Tona M…
MoreRelated News
16th HHT International Scientific Conference
Learn more curehht.org/scicon26
Comprehensive Guide to Managing Your Nosebleeds
December 1, 2025
67th ASH Annual Meeting and Exposition
October 2, 2025
2025 HHT Capitol Hill Day
August 6, 2025
2025 HHT Patient and Physician National Conference
July 23, 2025
